Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to -$1.8 million.

  • Bioventus' Change in Receivables rose 8930.77% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year decrease of 3890.94%. This contributed to the annual value of $10.7 million for FY2024, which is 20607.66% up from last year.
  • Bioventus' Change in Receivables amounted to -$1.8 million in Q3 2025, which was up 8930.77% from $13.6 million recorded in Q2 2025.
  • Over the past 5 years, Bioventus' Change in Receivables peaked at $25.6 million during Q3 2022, and registered a low of -$17.1 million during Q3 2024.
  • Over the past 5 years, Bioventus' median Change in Receivables value was $2.0 million (recorded in 2024), while the average stood at $2.2 million.
  • Per our database at Business Quant, Bioventus' Change in Receivables surged by 98974.36% in 2024 and then crashed by 55985.7% in 2025.
  • Quarter analysis of 5 years shows Bioventus' Change in Receivables stood at $6.9 million in 2021, then tumbled by 30.0% to $4.8 million in 2022, then skyrocketed by 90.23% to $9.2 million in 2023, then plummeted by 36.99% to $5.8 million in 2024, then plummeted by 131.49% to -$1.8 million in 2025.
  • Its Change in Receivables stands at -$1.8 million for Q3 2025, versus $13.6 million for Q2 2025 and -$9.0 million for Q1 2025.